. 2021 May 17;12:589273. doi: 10.3389/fphar.2021.589273
Copyright © 2021 Li, Li, Huang, Han, Tan, An, Xiang, Zhou, Yang and Cheng.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
FIGURE 6.
Summary of the underlying mechanism of dapagliflozin on alleviating hepatic steatosis.